Kelhia Sendeyo

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system.

A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system.

Journal: Oncoimmunology
Published: January 03, 2019

CMIP is a negative regulator of T cell signaling.

CMIP is a negative regulator of T cell signaling.

Journal: Cellular & molecular immunology
Published: December 01, 2018

Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.

Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.

Journal: PloS one
Published: August 22, 2018

NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome.

NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome.

Journal: Journal of autoimmunity
Published: August 25, 2017

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression.

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression.

Journal: PloS one
Published: July 10, 2015

Immunopathogenesis of idiopathic nephrotic syndrome with relapse.

Immunopathogenesis of idiopathic nephrotic syndrome with relapse.

Journal: Seminars in immunopathology
Published: November 04, 2013

Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy.

Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy.

Journal: Kidney international
Published: January 11, 2013

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.

Journal: Kidney international
Published: February 01, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026